INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
InfuSystem Holdings, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$13.74+0.34 (+2.54%)
Close on Oct 19, 2026
- Market cap
- $287.44M
- P/E (TTM)
- 33.5
- Dividend yield
- –
Share price
+$4.74 (+52.67%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
InfuSystem Holdings, Inc grew revenue 2.5% to $143.34M over the twelve months to Jun 30, 2026. Operating income rose 29.1% to $13.27M, moving the operating margin from 7.3% to 9.3%. Free cash flow was $22.91M, down 10.7% from a year earlier.
Revenue
$143.34M
+2.5% vs. a year earlier
Operating income
$13.27M
+29.1% vs. a year earlier
Free cash flow
$22.91M
-10.7% vs. a year earlier
EPS, diluted
$0.41
+78.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $287.44M
- P/E ratio
- 33.5
- Price to sales
- 2.01
- Price to book
- 4.86
- Dividend yield
- –
- Free cash flow yield
- 7.97%
Fundamentals
- Revenue
- $143.34M
- Net income
- $8.54M
- EPS, diluted
- $0.41
- Free cash flow
- $22.91M
- Book value per share
- $2.83
- Diluted shares
- 21M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$143.34M+2.5% YoY
Gross profit
$82.35M+7.9% YoY
Operating income
$13.27M+29.1% YoY
Net income
$8.54M+68.4% YoY
EPS, diluted
$0.41+78.3% YoY
Free cash flow
$22.91M-10.7% YoY
Reported periodTrailing twelve months